About California Pacific Medical Center Research Institute
Making a difference in patient's lives - one at a time.
Ongoing support from our community makes research possible.
Learn about how the CPMC Research Institute began.
Where care and science meet.
The Institutional Biosafety Committee oversees research at the institute.
California Pacific Medical Center Research Institute
475 Brannan Street, Suite 220
San Francisco, CA 94107
Sutter Health Research Institute Resources
California Pacific Medical Center Research Institute News
A study by Mohammed Kashani-Sabet, MD, California Pacific Medical Center Research Institute (CPMCRI) Senior Scientist, Medical Director of CPMC’s Cancer Programs, and Sutter Pacific Medical Foundation physician, was one of the Journal of the National Cancer Institute (JNCI)’s top fifty highest-cited articles published in 2013.
A key step in assessing a cancer patient’s stage and prognosis is checking their lymph nodes—small round organs that comprise the body’s lymphatic system—for signs of cancerous spread to other nearby nodes, organs and tissues. The sentinel lymph node (SLN) is the first lymph node to which cancer cells are most likely to spread from a primary tumor, and is often removed and examined in patients (especially those with breast cancer or melanoma) to determine whether cancer cells are present.
Time is of the essence for treating acute ischemic stroke (AIS) and preventing permanent damage to the brain. The only FDA-approved drug for acute ischemic stroke is recombinant tissue plasminogen activator (rt-PA/thrombolytic therapy), administered intravenously.